NPHS2 and focal segmental glomerulosclerosis: ,27 Other researchers have performed quantitative measurement of urinary podocyte-specific mRNAs, and showed correlations between relative increases of NPHS2 mRNA excretion and disease severity and progression in patients with MCD/FSGS and Alport syndrome.7